x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001105
| Product Information | |
|---|---|
| Product Name | Human Galanin ELISA Kit |
| Species | Human |
| Description | Human Galanin ELISA kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Galanin protein in human cell extract samples. It uses our proprietary ELISA technology. Quantitate human Galanin with 1.4 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Cell Lysate |
| Detection Range | 4.69 pg/mL - 300 pg/mL |
| Sensitivity | 1.4 pg/mL |
| Target Information | |
|---|---|
| Target Name | GAL |
| UniProt No. | P22466 |
| Gene ID | 51083 |
| Target Description | Contracts smooth muscle of the gastrointestinal and genitourinary tract, regulates growth hormone release, modulates insulin release, and may be involved in the control of adrenal secretion. |
| Alternative Names | GAL; GAL 1; GAL GMAP; GAL1; GALA_HUMAN; Galanin message associated peptide; Galanin message-associated peptide; Galanin precursor; Galanin prepropeptide; Galanin related peptide; Galanin/GMAP prepropeptide; GALN; GLNN; GMAP; MGC40167 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
